1. Fardal O, Drangsholt E, Olsen I. Palmar plantar keratosis and unusual periodontal findings. J Clin Periodontol. 1998;25(2):181-184. doi:10.1111/ j.1600-051x.1998.tb02425.x
2. Angel TA, Hsu S, Kornbleuth SI, Kornbleuth J, Kramer EM. Papillon-Lefevre syndrome: a case report of four affected siblings. J Am Acad Dermatol. 2002;46(1):8-10. doi:10.1067/mjd.2002.104968
3. Hart TC, Hart PS, Bowden DW, et al. Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome. J Med Genet. 1999; 36(12):881-887.
4. Machado RA, Cuadra-Zelaya FJM, Martelli-Júnior H, et al. Clinical and molecular analysis in Papillon-Lefèvre syndrome. Am J Med Genet A. 2019;179(10):2124-2131. doi:10.1002/ajmg.a.61285
5. Allende LM, Moreno A, de Unamuno P. A genetic study of cathepsin C gene in two families with Papillon-Lefevre syndrome. Mol Genet Metab. 2003;79(2):146-148. doi:10.1016/s1096-7192(03)00070-2
6. Sahar S, Abouzaid MR, Mostafa I, et al. Abnormal profiles of cathepsin C secreted in urine of Papillon Lefevre syndrome patients. Eur J Med Genet. 2022;65(10):600-605. doi:10.1016/j.ejmg.2022.104605
7. Bullón P, Castejón-Vega B, Román-Malo L, Jiménez-Guerrero M. Autophagic dysfunction in patients with Papillon-Lefevre syndrome is restored by recombinant cathepsin C treatment. J Allergy Clin Immunol. 2018;142(4):1131-1143. doi:10.1016/j.jaci.2018.01.018
8. Castejón-Vega B, Battino M, Quiles JL, Bullon B. Potential role of the mitochondria for the dermatological treatment of Papillon-Lefèvre. Antioxidants. 2021;10(1):95-100. doi:10.3390/antiox10010095
9. Giannetti L, Apponi R, Dello Diago AM, Jafferany M, Goldust M, Sadoughifar R. Papillon-Lefèvre syndrome: oral aspects and treatment. Dermatol Ther. 2020;33(3):155-160. doi:10.1111/dth.13336
10. Pacheco JJ, Coelho C, Salazar F, et al. Treatment of Papillon-Lefèvre syndrome periodontitis. J Clin Periodontol. 2002;29(4):370-374. doi:10. 1034/j.1600-051x.2002.290414.x
11. Albandar JM, Khattab R, Monem F, et al. The subgingival microbiota of Papillon-Lefevre syndrome. J Periodontol. 2011;28(5):400-414. doi:10. 1902/jop.2011.110450
12. Colombo AP, Boches SK, Cotton SL, et al. Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray. J Periodontol. 2009;80(9):1421-1432. doi:10.1902/jop.2009. 090185
13. Robertson KL, Drucker DB, James J, et al. A microbiological study of Papillon-Lefèvre syndrome in two patients. J Clin Pathol. 2001;54(5): 371-376. doi:10.1136/jcp.54.5.371
14. Wiebe CB, Hakkinen L, Putnins EE, et al. Successful periodontal maintenance of a case with Papillon-Lefevre syndrome: 12-year follow-up and review of the literature. J Periodontol. 2001;72(6):824-830. doi: 10.1902/jop.2001.72.6.824
15. Hart TC, Shapira L. Papillon-Lefèvre syndrome. Periodontol. 1994;6: 88-100. doi:10.1111/j.1600-0757.1994.tb00029.x
16. Firatli E, Tuzun B, Efeoglu A. Papillon-Lefèvre syndrome: analysis of neutrophil chemotaxis. J Periodontol. 1996;67:617-620. doi:10.1902/jop. 1996.67.6.617
17. Lundgren T, Parhar RS, Renvert S, et al. Impaired cytotoxicity in Papillon-Lefèvre syndrome. J Dent Res. 2005;84(5):414-417. doi:10.1177/ 154405910508400503
18. Lyberg T. Immunological and metabolical studies in two siblings with Papillon-Lefevre syndrome. J Periodontol Res. 1982;17(6):563-568. doi: 10.1111/j.1600-0765.1982.tb01177.x
19. Preus HR, Morland B. In vitro studies of monocyte function in two siblings with Papillon-Lefevre syndrome. Scand J Dent Res. 1987;95(1): 59-64. doi:10.1111/j.1600-0722.1987.tb01394.x
20. Celenligil H, Kansu E, Ruacan S, et al. Papillon-Lefèvre syndrome: characterization of peripheral blood and gingival lymphocytes with monoclonal antibodies. J Periodontol. 1992;19(6):392-397. doi:10.1111/j. 1600-051x.1992.tb00668.x
21. Firatli E, Gurel N, Efeoglu A. Papillon-Lefevre syndrome: analysis of peripheral blood lymphocyte subsets. J Clin Periodontol. 1996;23(9): 823-825. doi:10.1111/j.1600-051x.1996.tb00618.x
22. Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev. 2001; 14(4):727-752. doi:10.1128/CMR.14.4.727-752.2001
23. Lamster IB, Smith QT, Celenti RS, et al. Development of a risk profile for periodontal disease: microbial and host response factors. J Periodontol. 1994;65(Suppl 5S):511-520. doi:10.1902/jop.1994.65.5s.511
24. Ullbro C, Crossner CG, Nederfors T, et al. Dermatologic and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol. 2003;48(3):345-351. doi:10.1067/mjd.2003.197
25. Hart TC, Hart PS, Michalec MD, et al. Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C.J Med Genet. 2000;37(2):88-94. doi:10.1136/jmg.37.2.88
26. Dababneh RH, Jebrin SE, Khouri AT, Bissada NF. Papillon-Lefèvre or Haim-Munk syndrome? Report on two sisters in a consanguineous family. Clin Adv Periodontics. 2015;5(3):192-200. doi:10.1902/cap.2014. 130089
27. Almuneef M, Al Khenaizan S, Al Ajaji S, et al. Pyogenic liver abscess and Papillon-Lefevre syndrome: not a rare association. Pediatrics. 2003; 111(1):85-88. doi:10.1542/peds.111.1.e85
28. Morgan RD, Hannon E, Lakhoo K. Renal abscess in Papillon-Lefevre syndrome. Pediatr Surg Int. 2011;27(12):1381-1383. doi:10.1007/s00383-011-2931-3
29. Gorlin RJ, Sedano H. The syndrome of palmar-plantar hyperkeratosis and premature periodontal destruction of the teeth: a clinical and genetic analysis of the Papillon-Lefevre syndrome. J Pediatr. 1964;65: 895-908. doi:10.1016/s0022-3476(64)80014-7
30. Jain V, Gupta R, Parkash H. Prosthodontic rehabilitation in Papillon-Lefevre syndrome: a case report. J Indian Soc Pedod Prev Dent. 2005; 23(2):96-98. doi:10.4103/0970-4388.16451
31. Bas AY, Yilmaz G, Ertan U, et al. Papillon-Lefevre syndrome: a case report. Int Pediatr. 2004;19:224-225.
32. Mashhood AA, Humayun A, Saleem M, et al. Papillon-Lefevre syndrome associated with pseudoainhum. J Am Acad Dermatol. 2004; 51(2 Suppl):S134-S136. doi:10.1016/j.jaad.2004.03.021
33. Ramesh M, Santosh G, Honavar MD, et al. Ocular surface squamous neoplasia in Papillon-Lefevre syndrome. Am J Ophthalmol. 2005;139(1): 207-209. doi:10.1016/j.ajo.2004.07.028
34. Shapira J, Eidelman E, Fuks A, Hacham-Zadeh S. Treatment of Papillon-Lefevre syndrome with chemotherapy: report of cases.Spec Care Dentist. 1985;5(2):71-74. doi:10.1111/j.1754-4505.1985.tb00389.x
35. Etöz OA, Ulu M, Kesim B. Treatment of patient with Papillon-Lefevre syndrome with short dental implants: a case report.Implant Dent. 2010; 19(5):394-399. doi:10.1097/ID.0b013e3181ed0798
36. Leuenberger M, Fischer L, Mylonas A, et al. Papillon-Lefevre syndrome treated by acitretin: case report and cytokine profile. JEADV. 2022; 36(12):235-238. doi:10.1111/jdv.17772
37. Sarma N, Ghosh C, Kar S, Bazmi BA. Low-dose acitretin in Papillon-Lefevre syndrome: treatment and 1-year follow-up. Dermatol Ther. 2014;46(4):135-138. doi:10.1111/dth.12177
38. Lee MR, Wong LCF, O'Fischer G. Papillon-Lefevre syndrome treated with acitretin. Australas J Dermatol. 2005;46(3):199-201. doi:10.1111/j. 1440-0960.2005.00180.x
39. Kellum R. Papillon-Lefevre syndrome in four siblings treated with etretinate: a nine-year evaluation. Int J Dermatol. 1989;28(9):605-608. doi:10.1111/j.1365-4362.1989.tb02539.x